Literature DB >> 8846166

Lower frequency of allele loss on chromosome 18q in human breast cancer than in colorectal tumors.

M Schenk1, C Leib-Mösch, I U Schenck, M Jaenicke, S Indraccolo, H D Saeger, G Dallenbach-Hellweg, R Hehlmann.   

Abstract

Inactivation of tumor suppressor genes is thought to be a critical step in tumorigenesis. The DCC (deleted in colorectal carcinoma) gene, located on the long arm of chromosome 18, has been shown to be frequently deleted in colorectal tumors. To investigate the involvement of allelic deletions on chromosome 18q in breast cancer tumorigenesis we analyzed 28 primary breast tumors and 28 colorectal tumors (24 carcinomas, 4 adenomas) with four different polymorphic DNA markers detecting RFLPs on chromosome 18q. In breast cancer we found loss of heterozygosity (LOH) in 4 of 27 (15%) informative cases whereas 15 of 25 (60%) colorectal tumors showed allelic deletions. In all cases of allelic loss the DCC locus or its proximal vicinity (locus SSAV1) were involved. LOH on chromosome 18q occurs both in breast and colorectal cancer, yet the frequency of these deletions in breast tumors is lower than in colorectal tumors. Moreover, in breast cancer these mutations were only detected in large and undifferentiated tumors.

Entities:  

Mesh:

Year:  1996        PMID: 8846166     DOI: 10.1007/bf01575448

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  23 in total

1.  Two RFLPs associated with the human endogenous retroviral element S71 on chromosome 18q21.

Authors:  C Leib-Mösch; D Barton; E M Geigl; R Brack-Werner; V Erfle; R Hehlmann; U Francke
Journal:  Nucleic Acids Res       Date:  1989-03-25       Impact factor: 16.971

2.  Correlation of loss of alleles on the short arms of chromosomes 11 and 17 with metastasis of primary breast cancer to lymph nodes.

Authors:  K Takita; T Sato; M Miyagi; M Watatani; F Akiyama; G Sakamoto; F Kasumi; R Abe; Y Nakamura
Journal:  Cancer Res       Date:  1992-07-15       Impact factor: 12.701

3.  The DCC gene: structural analysis and mutations in colorectal carcinomas.

Authors:  K R Cho; J D Oliner; J W Simons; L Hedrick; E R Fearon; A C Preisinger; P Hedge; G A Silverman; B Vogelstein
Journal:  Genomics       Date:  1994-02       Impact factor: 5.736

4.  Allelotype analysis of esophageal squamous cell carcinoma.

Authors:  I Shibagaki; Y Shimada; T Wagata; M Ikenaga; M Imamura; K Ishizaki
Journal:  Cancer Res       Date:  1994-06-01       Impact factor: 12.701

5.  Identification of a chromosome 18q gene that is altered in colorectal cancers.

Authors:  E R Fearon; K R Cho; J M Nigro; S E Kern; J W Simons; J M Ruppert; S R Hamilton; A C Preisinger; G Thomas; K W Kinzler
Journal:  Science       Date:  1990-01-05       Impact factor: 47.728

6.  Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas.

Authors:  T I Andersen; A Gaustad; L Ottestad; G W Farrants; J M Nesland; K M Tveit; A L Børresen
Journal:  Genes Chromosomes Cancer       Date:  1992-03       Impact factor: 5.006

7.  Allelic loss of chromosome 18q and prognosis in colorectal cancer.

Authors:  J Jen; H Kim; S Piantadosi; Z F Liu; R C Levitt; P Sistonen; K W Kinzler; B Vogelstein; S R Hamilton
Journal:  N Engl J Med       Date:  1994-07-28       Impact factor: 91.245

8.  Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer.

Authors:  T Sato; A Tanigami; K Yamakawa; F Akiyama; F Kasumi; G Sakamoto; Y Nakamura
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

9.  Loss of heterozygosity on chromosomes 17 and 18 in breast carcinoma: two additional regions identified.

Authors:  C S Cropp; R Lidereau; G Campbell; M H Champene; R Callahan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

10.  Analysis of genetic alterations related to the development and progression of breast carcinoma.

Authors:  K Nagayama; M Watatani
Journal:  Jpn J Cancer Res       Date:  1993-11
View more
  2 in total

1.  Identification of germline alterations of the mad homology 2 domain of SMAD3 and SMAD4 from the Ontario site of the breast cancer family registry (CFR).

Authors:  Eric Tram; Irada Ibrahim-Zada; Laurent Briollais; Julia A Knight; Irene L Andrulis; Hilmi Ozcelik
Journal:  Breast Cancer Res       Date:  2011-08-11       Impact factor: 6.466

Review 2.  An epigenetic regulator: methyl-CpG-binding domain protein 1 (MBD1).

Authors:  Lu Li; Bi-Feng Chen; Wai-Yee Chan
Journal:  Int J Mol Sci       Date:  2015-03-05       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.